CBA
TCON

Coastal Bridge Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Coastal Bridge Advisors’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$14.9K – 182
2022
Q4 		$14.9K Buy
+500
New +$15.1K ﹤0.01% 169
2022
Q1 		– Sell
-595
Closed -$32K – 231
2021
Q4 		$32K Buy
+595
New +$38K 0.01% 205

Other funds holding TCON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Coastal Bridge Advisors's TCON Position: Q1 2023 in Review

Coastal Bridge Advisors sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2023, closing a stake of 500 shares — an estimated $14.9K sold.

Coastal Bridge Advisors first reported a position in TCON in Q4 2021 and held it in 2 quarters. The position peaked at $32K in Q4 2021. 32 funds tracked by Wall St. Rank hold TCON as of Q1 2023.

  • Coastal Bridge Advisors reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Coastal Bridge Advisors sold 500 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $14.9K.
  • Coastal Bridge Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Coastal Bridge Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $32K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Coastal Bridge Advisors's 13F filing for Q1 2023, filed 15 May 2023.